Biocryst Pharmaceuticals Overview
Biocryst Pharmaceuticals Target Price
Analysts' 12-month price predictions for BCRX.
Get informed when a big investor buys or sells
+ FollowShare Price
$9.06
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-11-05 | JMP SecuritiesJonathan Wolleben | $25 |  175.9% upside |  |
| 2025-11-04 | Barclays | $9 |  0.7% downside | |
| 2025-10-14 | JefferiesMaury Raycroft | $15 | 65.6% upside | |
| 2025-10-14 | RBC Capital | $15 | 65.6% upside | |
| 2025-10-01 | Evercore ISI | $8 | 11.7% downside | |
| 2024-08-06 | BarclaysGena Wang | $7 | 22.7% downside | |
| 2024-08-05 | JefferiesMaury Raycroft | $11 | 21.4% upside | |
| 2022-11-02 | Evercore ISILiisa Bayko | $16 | 76.6% upside | |
| 2022-08-23 | BarclaysGena Wang | $14 | 54.5% upside | |
| 2022-01-10 | Cowen & Co.Ken Cacciatore | $25 | 175.9% upside | |
| 2021-11-03 | Cantor FitzgeraldBrian Cheng | $21 | 131.8% upside | |
| 2021-08-09 | JefferiesMaury Raycroft | $19 | 109.7% upside | |